Publication Topic

Xue Y, Wang L, Huo R, Chen M, Melo B, Dingley K, et al. 2024. 1β-Hydroxydeoxycholic acid as an endogenous biomarker in human plasma for assessment of CYP3A clinical drug-drug interaction potential. Drug Metab Dispos 52(9):966–974; doi: 10.1124/dmd.124.001680. PMID: 38991779.

Williams Z, Covell L, Tung P, Bloomquist TR, Schilling K, Deyssenroth M, et al. Investigating the influence of prenatal metals exposures on childhood mitochondrial biomarkers. Poster presentation P532 at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024. In: The Toxicologist 198(S1):223, Abstract 3389.

Mease K, Kimzey A, Lansita J. 2017. Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design. Curr Opin Toxicol 4(June):1–15; doi: 10.1016/j.cotox.2017.03.005.